Avanos Medical, Inc.
AVNS
$12.71
-$0.39-2.98%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.34% | 2.15% | -0.01% | -0.03% | -0.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.34% | 2.15% | -0.01% | -0.03% | -0.58% |
| Cost of Revenue | 5.35% | 4.39% | 3.13% | 3.86% | 3.13% |
| Gross Profit | -1.77% | 0.42% | -2.40% | -2.91% | -3.28% |
| SG&A Expenses | -5.15% | -4.85% | -9.23% | -9.20% | -1.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -47.83% | -9.09% | 0.00% | 16.22% | -30.30% |
| Total Operating Expenses | -0.57% | -0.63% | -3.53% | -3.49% | 0.05% |
| Operating Income | 37.10% | 79.49% | 84.56% | 88.67% | -11.08% |
| Income Before Tax | -14,733.33% | -5,005.06% | 1,144.00% | 37.25% | -88.21% |
| Income Tax Expenses | -446.51% | -950.00% | -49.43% | 337.50% | -17.31% |
| Earnings from Continuing Operations | -23,662.50% | -3,802.02% | 293.75% | -18.60% | -109.04% |
| Earnings from Discontinued Operations | 92.74% | 88.82% | 86.43% | 101.57% | -325.28% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -518.33% | -534.47% | 128.34% | 121.39% | -239.46% |
| EBIT | 37.10% | 79.49% | 84.56% | 88.67% | -11.08% |
| EBITDA | 17.72% | 30.79% | 32.37% | 22.51% | -11.66% |
| EPS Basic | -530.36% | -546.92% | 128.82% | 121.93% | -238.98% |
| Normalized Basic EPS | 85.27% | 210.07% | 186.44% | 171.94% | -18.46% |
| EPS Diluted | -530.44% | -545.74% | 127.74% | 120.94% | -241.08% |
| Normalized Diluted EPS | 84.58% | 210.84% | 187.41% | 175.53% | -17.95% |
| Average Basic Shares Outstanding | -1.08% | -1.23% | -1.29% | -0.75% | -0.48% |
| Average Diluted Shares Outstanding | -0.64% | -0.64% | -0.53% | -0.53% | -0.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |